322 related articles for article (PubMed ID: 17381185)
1. Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.
Botteman MF; Ozminkowski RJ; Wang S; Pashos CL; Schaefer K; Foley DJ
CNS Drugs; 2007; 21(4):319-34. PubMed ID: 17381185
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.
Snedecor SJ; Botteman MF; Bojke C; Schaefer K; Barry N; Pickard AS
Sleep; 2009 Jun; 32(6):817-24. PubMed ID: 19544759
[TBL] [Abstract][Full Text] [Related]
3. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
[TBL] [Abstract][Full Text] [Related]
4. Eszopiclone for late-life insomnia.
McCrae CS; Ross A; Stripling A; Dautovich ND
Clin Interv Aging; 2007; 2(3):313-26. PubMed ID: 18044182
[TBL] [Abstract][Full Text] [Related]
5. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
Walsh JK; Krystal AD; Amato DA; Rubens R; Caron J; Wessel TC; Schaefer K; Roach J; Wallenstein G; Roth T
Sleep; 2007 Aug; 30(8):959-68. PubMed ID: 17702264
[TBL] [Abstract][Full Text] [Related]
6. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Najib J
Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
[TBL] [Abstract][Full Text] [Related]
7. Eszopiclone: a review of its use in the treatment of insomnia.
Hair PI; McCormack PL; Curran MP
Drugs; 2008; 68(10):1415-34. PubMed ID: 18578559
[TBL] [Abstract][Full Text] [Related]
8. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
Krystal AD; Walsh JK; Laska E; Caron J; Amato DA; Wessel TC; Roth T
Sleep; 2003 Nov; 26(7):793-9. PubMed ID: 14655910
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.
Spierings EL; McAllister PJ; Bilchik TR
Cranio; 2015 Apr; 33(2):115-21. PubMed ID: 25323219
[TBL] [Abstract][Full Text] [Related]
10. Eszopiclone: esopiclone, estorra, S-zopiclone, zopiclone--Sepracor.
Drugs R D; 2005; 6(2):111-5. PubMed ID: 15777104
[TBL] [Abstract][Full Text] [Related]
11. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y
Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
[TBL] [Abstract][Full Text] [Related]
12. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S
Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802
[TBL] [Abstract][Full Text] [Related]
13. Eszopiclone (Lunesta) for treatment of transient and chronic insomnia.
Wessell AM; Weart CW
Am Fam Physician; 2005 Jun; 71(12):2359-60. PubMed ID: 15999875
[No Abstract] [Full Text] [Related]
14. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
Roth T; Walsh JK; Krystal A; Wessel T; Roehrs TA
Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
[TBL] [Abstract][Full Text] [Related]
15. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
Jhaveri M; Seal B; Pollack M; Wertz D
Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
[TBL] [Abstract][Full Text] [Related]
16. The role of eszopiclone in the treatment of insomnia.
Morin AK; Willett K
Adv Ther; 2009 May; 26(5):500-18. PubMed ID: 19513631
[TBL] [Abstract][Full Text] [Related]
17. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
[TBL] [Abstract][Full Text] [Related]
18. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
19. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
Scharf M; Erman M; Rosenberg R; Seiden D; McCall WV; Amato D; Wessel TC
Sleep; 2005 Jun; 28(6):720-7. PubMed ID: 16477959
[TBL] [Abstract][Full Text] [Related]
20. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L
Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
